Crinetics (CRNX) news
Recent news
Crinetics Pharmaceuticals Inc. anticipated last trading date Aug. 31, Nasdaq says
Crinetics Pharmaceuticals Inc. (CRNX) is expected to complete its final trading session on the Nasdaq on August 31, 2026, according to Nasdaq listings confirmation . This marks the anticipated last date on which the company’s common stock will be available for trading on the exchange. The move…
AInvest Wire · 3h agoNasdaq unofficially closes down 124.63 points, or 0.47 percent, at 26,416.72
The Nasdaq Composite unofficially closed down 124.63 points, or 0.47 percent, at 26,416.72 on Wednesday, reflecting ongoing selling pressure in the technology-heavy index. This decline follows a volatile session in which the index initially dropped sharply before staging a partial recovery. Earlier…
AInvest Wire · 2d agoCrinetics Pharmaceuticals: will not be providing updated guidance and is withdrawing its previously issued guidance
AInvest Wire · Aug 3, 2026Crinetics Pharmaceuticals Inc: UBS cuts to neutral from buy; cuts target price to $85 from $55
AInvest Wire · Jul 28, 2026Crinetics Pharmaceuticals Inc: Jefferies cuts to hold from buy
AInvest Wire · Jul 7, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.